N-acetyl semax and selank amidate: is there any human data?

The short answer: N-acetyl semax and selank amidate are chemically modified versions of two Russian nasal peptides, and no human study has tested either one. The modifications are real chemistry, and a few lab studies from the developers and one Italian group have looked at acetylated semax. [9] But the claims that these versions are stronger, longer lasting or better absorbed have never been checked in people. The original peptides themselves have only small, open-label human studies behind them. [2]

This post explains what the modifications are, what the lab data show, and where the evidence stops. It does not name products or brands, and it does not give doses.

What are N-acetyl semax and selank amidate?

Semax is a seven amino acid fragment of the hormone ACTH, and selank is a seven amino acid analog of the immune peptide tuftsin. Both end in the same Pro-Gly-Pro tail, which was added to protect them from breakdown.

The modified versions change the two ends of the chain:

• N-acetyl (acetylation) adds a small acetyl group to the first amino acid, capping the free amino group at the start of the chain.
• Amidate (amidation) replaces the free acid group at the last amino acid with an amide, capping the end of the chain.

Sellers use these terms alone and together, so you will see "N-acetyl semax", "semax amidate", "N-acetyl semax amidate", "N-acetyl selank" and "selank amidate". They are all new molecules. None is the Russian registered semax or selank.

What does acetylation change?

The general idea is sound. A 2006 review of ways to extend the life of peptide drugs in the blood lists modification of the N- and C-terminus among the standard strategies, because many enzymes that break peptides down start at the ends. [4] Ordinary semax does break down quickly: in rats given intranasal semax, the peptide was rapidly degraded and its Pro-Gly-Pro fragment dominated blood and tissue samples. [3] Enzymes from nasal mucus, brain membranes and blood all cleave it. [8]

The developing institute has published short reports on how acetylated semax and semax analogs with different first amino acids stand up to protein-cutting enzymes in biological fluids. [6] [7] These are test-tube and tissue studies. They did not measure effects in animals or people, and PubMed lists no English abstract for them.

The one detailed study found a trade-off rather than an upgrade. An Italian group compared semax and acetylated semax in the lab. Acetylation changed how the peptide binds copper, and unlike semax, the acetylated form did not protect human neuroblastoma cells from copper-induced toxicity. The authors concluded that the free amino group at the start of semax plays a crucial role in that protection. [9] In other words, capping the end that sellers say makes semax better removed one of its measured protective effects in cells.

What does amidation change?

Changing the C-terminus is one of the standard ways to shield a peptide drug from enzymes that trim the end of the chain. [4] Melanotan II, a synthetic hormone analog first given to people in a 1996 pilot study, carries both an acetyl cap (Ac-) at the start and an amide (-NH2) at the end. [1] That shows the chemistry is used in real drug design. It does not tell us what amidation does to semax or selank.

We found no published study, in cells, animals or people, of amidated selank or amidated semax. Claims about better brain penetration, longer action or stronger effects for these versions are extrapolations from general peptide chemistry, not findings.

Is there any human data on the modified versions?

No. As of September 2026 we found no human study of N-acetyl semax, semax amidate, N-acetyl selank or selank amidate in PubMed.

For context, the human evidence for the unmodified peptides is already limited:

• Semax has open-label Russian studies in stroke that added it to standard care, without blinding or placebo. [2]
• Selank has small Russian anxiety studies, including one of 62 patients compared against the benzodiazepine medazepam, without a placebo arm. [5]

The modified versions do not inherit this evidence. A new molecule can be absorbed, broken down and bound to receptors differently, as the copper study showed for acetylated semax. [9] "Stronger" is a marketing claim until someone runs the study.

Are they safe?

Unknown. There is no safety study of any modified version. Quality adds a second layer of risk: when a Belgian medicines laboratory analyzed seized preparations, it found semax and selank in products that had not been through clinical trials and noted that such peptides were freely sold online as injectable powders and nasal sprays. [10] A research-labeled vial or spray of a modified analog has no verified identity, purity or strength.

Are N-acetyl semax and selank amidate legal?

The legal status of the parent peptides does not carry over.

• Semax is not on the 503A bulks list today, and neither is selank. [11] The modified versions are not listed either.
• The Pharmacy Compounding Advisory Committee recommended semax for the bulks list on July 23 to 24, 2026. That vote concerned semax. It did not cover a chemically different analog, and selank was not part of the recommendation. [12]
• For athletes, a pharmacological substance that is not covered elsewhere on the list and has no approval from any government health authority falls under section S0 of the WADA Prohibited List. Neither modified version is approved anywhere, so athletes should treat them as prohibited unless their anti-doping organization says otherwise. [13]

Track the parent peptides on the semax regulatory tracker and the selank regulatory tracker. The legal hub covers state rules, and the PCAC vote explainer covers what the July meeting did and did not decide.

For which peptides have a lawful prescription route today, see how to get peptides prescribed; for what clinics mean when they sell these as peptide therapy, see our explainer.

How this fits with the rest of the semax and selank evidence

If you are comparing the two parent peptides, start with the semax vs selank comparison. For the route question, see semax nasal spray and selank nasal spray, which also covers why no trial has tested the two together.

The bottom line

Acetylation and amidation are real tools in peptide drug design, and they can slow enzyme breakdown. For semax and selank, the only detailed study of a modified version found that acetylation removed a protective effect in cells. There is no animal or human evidence that N-acetyl semax, selank amidate or the combined forms work better, and no evidence that they are safe. Neither has a lawful route to patients in the United States.